HR7189-119

In Committee

PrEP Access Act

119th Congress Introduced Jan 21, 2026

Summary

What This Bill Does

The PrEP Access Act expands Medicare Part B to cover pharmacist-provided HIV prevention services. Covered services are those a pharmacist is legally authorized to furnish under State law and that would otherwise be covered if provided by a physician or incident to a physician service. The covered category includes evaluation, management, screening, consultation, and counseling related to pre-exposure prophylaxis, post-exposure prophylaxis, other evidence-based HIV prevention interventions, medication administration for those interventions, and related clinical diagnostic laboratory tests. Medicare payment is set at 80 percent of the lesser of the actual charge or 85 percent of the physician-fee-schedule payment basis. The bill updates practitioner billing provisions to include pharmacists and adds a reasonable-and-necessary limit for pharmacist-provided HIV prevention services. The amendments apply to items and services furnished on or after January 1, 2027.

Who Benefits and How

Medicare beneficiaries seeking HIV prevention, people who need PrEP or PEP access, pharmacists authorized under State law, pharmacies, HIV prevention programs, and public health clinics benefit because Medicare would pay for pharmacist-furnished prevention services that can be easier to access than physician offices. Beneficiaries may gain access to medication administration, counseling, screening, and related lab testing through pharmacies. Pharmacists and pharmacies gain a new Medicare-covered service category.

Who Bears the Burden and How

CMS, Medicare Administrative Contractors, pharmacists, pharmacies, and billing compliance staff must implement new Part B coverage, payment, reasonable-and-necessary determinations, state-scope checks, claims processing, and documentation for HIV prevention services beginning January 1, 2027. Federal taxpayers and Medicare Part B finances bear the cost of new covered services. Physicians may see some HIV prevention service volume shift to pharmacists.

Key Provisions

  • Adds pharmacist-provided HIV prevention services to Medicare Part B.
  • Covers pharmacist-furnished evaluation, management, screening, consultation, counseling, medication administration, and related laboratory testing.
  • Limits coverage to services pharmacists are legally authorized to furnish under State law.
  • Includes PrEP, PEP, and other evidence-based HIV prevention interventions.
  • Sets payment at 80 percent of the lesser of actual charges or 85 percent of the physician-fee-schedule amount.
  • Applies the amendments to items and services furnished on or after January 1, 2027.

Evidence Chain:

This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.

At a Glance

What This Bill Does

Adds pharmacist-provided HIV prevention services to Medicare Part B beginning January 1, 2027, covering pharmacist-furnished evaluation, management, screening, consultation, counseling, medication administration, and diagnostic laboratory-test services related to PrEP, PEP, and other evidence-based HIV prevention interventions when authorized under State law, and pays 80 percent of the lesser of actual charges or 85 percent of the physician-fee-schedule amount.

Key Policy Areas

Healthcare, Pharmaceuticals, Medicare

Primary Purpose

Adds pharmacist-provided HIV prevention services to Medicare Part B beginning January 1, 2027, covering pharmacist-furnished evaluation, management, screening, consultation, counseling, medication administration, and diagnostic laboratory-test services related to PrEP, PEP, and other evidence-based HIV prevention interventions when authorized under State law, and pays 80 percent of the lesser of actual charges or 85 percent of the physician-fee-schedule amount.

Policy Domains

Healthcare Pharmaceuticals Medicare

Substantive provisions

Identified Gains
  • Medicare beneficiaries seeking HIV prevention
  • PrEP patients
  • PEP patients
  • Pharmacists
  • Pharmacies
  • HIV prevention programs
  • Public health clinics
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
Pharmacies: , , , ,
Pharmacists: , , , ,
PEP patients: , , , ,
PrEP patients: , , , ,
Public health clinics: , , , ,
HIV prevention programs: , , , ,
Medicare beneficiaries seeking HIV prevention: , , , ,
Identified Costs
  • CMS
  • Medicare Administrative Contractors
  • Pharmacy billing staff
  • Federal taxpayers
  • Physicians providing HIV prevention
Model: codex-gpt-5 | Version: bill_summary_v2 | Source: ih
CMS: , , , ,
Federal taxpayers: , , , ,
Pharmacy billing staff: , , , ,
Medicare Administrative Contractors: , , , ,
Physicians providing HIV prevention: , , , ,

Legislative Progress

In Committee
Introduced Committee Passed
Jan 21, 2026

Mr. Pocan (for himself, Mrs. Beatty, Ms. Dean of Pennsylvania, …

Jan 21, 2026

Referred to the Committee on Energy and Commerce, and in …

Jan 21, 2026

Introduced in House

Stakeholder Effects

cui bono?

How this legislation distributes effects. Mention counts reflect frequency, not effect magnitude.

Healthcare
5 mentions across 1 clause
+4 positive -1 negative

Medicare Administrative Contractors, Medicare beneficiaries seeking HIV prevention, PEP patients

Positive-direction: Medicare beneficiaries seeking HIV prevention, PEP patients, Pharmacists, PrEP patients

Negative-direction: Medicare Administrative Contractors

Pharmaceuticals
1 mention across 1 clause
+1 positive

Pharmacies

Government
1 mention across 1 clause
-1 negative

CMS

Taxpayers
1 mention across 1 clause
-1 negative

Taxpayers

1/2
sections analyzed
Full impact breakdown

Bill Structure & Actor Mappings

Who is "The Secretary" in each section?

Domains
Healthcare Pharmaceuticals Medicare

We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.

Learn more about our methodology